Cost-comparisons are used when a new intervention is estimated to have similar clinical benefit as a NICE recommended treatment at a similar cost.
Off
SCHARR-TAG evaluates the comparative efficacy and the difference in total acquisition and administration costs of the new intervention with the NICE recommended treatment.
